Venatorx Pharmaceuticals is a private pharmaceutical company focused on improving health outcomes for patients with multi-drug-resistant bacterial infections and hard-to-treat viral infections.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
taniborbactam (fka VNRX-5133)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):